|
Laboratory data (mean ± SE)
|
Living liver donor (n = 5)
|
Without chemotherapy (n = 9)
|
With chemotherapy (n = 8)
|
p value*
|
|---|
|
T-Bill (mg/dl)
| | | | |
|
Preoperative
|
0.69 ± 0.05
|
0.77 ± 0.18
|
0.45 ± 0.04
|
0.03
|
|
5 postoperative days
|
1.64 ± 0.44
|
1.42 ± 0.27
|
1.28 ± 0.27
|
0.81
|
|
Early period
|
0.93 ± 0.20
|
0.80 ± 0.21
|
1.60 ± 1.02
|
0.61
|
|
Late period
|
0.79 ± 0.11
|
0.72 ± 0.08
|
0.74 ± 0.08
|
0.97
|
|
PT-INR
| | | | |
|
Preoperative
|
0.97 ± 0.02
|
0.96 ± 0.02
|
0.97 ± 0.03
|
0.82
|
|
5 postoperative days
|
1.11 ± 0.03
|
1.12 ± 0.03
|
1.10 ± 0.04
|
0.81
|
|
Early period
|
1.07 ± 0.05
|
1.01 ± 0.03
|
1.05 ± 0.04
|
0.68
|
|
Late period
|
0.95 ± 0.01
|
0.94 ± 0.03
|
1.02 ± 0.03
|
0.19
|
|
Plt (
×
10
3
μl)
| | | | |
|
Preoperative
|
25.7 ± 1.6
|
22.5 ± 1.3
|
25.3 ± 1.9
|
0.35
|
|
5 postoperative days
|
19.7 ± 1.4
|
16.8 ± 1.3
|
16.8 ± 2.0
|
0.4
|
|
Early period
|
25.7 ± 1.9
|
16.8 ± 1.3
|
26.6 ± 3.7
|
0.16
|
|
Late period
|
22.1 ± 0.9
|
20.2 ± 2.9
|
19.4 ± 2.2
|
0.1
|
|
Alb (g/Dl)
| | | | |
|
Preoperative
|
4.3 ± 0.1
|
4.0 ± 0.2
|
3.9 ± 0.2
|
0.22
|
|
5 postoperative days
|
3.1 ± 0.1
|
3.1 ± 0.1
|
2.9 ± 0.1
|
0.55
|
|
Early period
|
3.6 ± 0.2
|
3.5 ± 0.2
|
3.5 ± 0.2
|
0.74
|
|
Late period
|
4.2 ± 0.1
|
3.9 ± 0.2
|
3.4 ± 0.3
|
0.003
|
- p values* compare variables by the Kruskal-Wallis test among the three groups.
